This phase II/III trial studies how well methylphenidate and exercise work in reducing
cancer-related fatigue in patients with prostate cancer. Methylphenidate is a type of central
nervous system stimulant that can improve cognitive ability, mainly in memory and cognitive
function. Exercise can improve mood and the physical aspects of cancer-related fatigue.
Giving methylphenidate in combination with exercise may work better in reducing
cancer-related fatigue in patients with prostate cancer.
Intervention
Exercise Intervention, Methylphenidate, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Stretching
Condition
Prostate Carcinoma
Investigators
Sriram Yennu